Literature DB >> 15772068

The fusion activity of HIV-1 gp41 depends on interhelical interactions.

Tara R Suntoke1, David C Chan.   

Abstract

Infection by human immunodeficiency virus type I requires the fusogenic activity of gp41, the transmembrane subunit of the viral envelope protein. Crystallographic studies have revealed that fusion-active gp41 is a "trimer-of-hairpins" in which three central N-terminal helices form a trimeric coiled coil surrounded by three antiparallel C-terminal helices. This structure is stabilized primarily by hydrophobic, interhelical interactions, and several critical contacts are made between residues that form a deep cavity in the N-terminal trimer and the C-helix residues that pack into this cavity. In addition, the trimer-of-hairpins structure has an extensive network of hydrogen bonds within a conserved glutamine-rich layer of poorly understood function. Formation of the trimer-of-hairpins structure is thought to directly force the viral and target membranes together, resulting in membrane fusion and viral entry. We test this hypothesis by constructing four series of gp41 mutants with disrupted interactions between the N- and C-helices. Notably, in the three series containing mutations within the cavity, gp41 activity correlates well with the stability of the N-C interhelical interaction. In contrast, a fourth series of mutants involving the glutamine layer residue Gln-653 show fusion defects even though the stability of the hairpin is close to wild-type. These results provide evidence that gp41 hairpin stability is critical for mediating fusion and suggest a novel role for the glutamine layer in gp41 function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15772068     DOI: 10.1074/jbc.M502196200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.

Authors:  Yael Wexler-Cohen; Avraham Ashkenazi; Mathias Viard; Robert Blumenthal; Yechiel Shai
Journal:  FASEB J       Date:  2010-07-06       Impact factor: 5.191

2.  Synergistic inhibition of HIV-1 envelope-mediated membrane fusion by inhibitors targeting the N and C-terminal heptad repeats of gp41.

Authors:  Elena Gustchina; John M Louis; Carole A Bewley; G Marius Clore
Journal:  J Mol Biol       Date:  2006-09-12       Impact factor: 5.469

3.  Cell-cell and virus-cell fusion assay-based analyses of alanine insertion mutants in the distal α9 portion of the JRFL gp41 subunit from HIV-1.

Authors:  Mizuki Yamamoto; Qingling Du; Jiping Song; Hongyun Wang; Aya Watanabe; Yuetsu Tanaka; Yasushi Kawaguchi; Jun-Ichiro Inoue; Zene Matsuda
Journal:  J Biol Chem       Date:  2019-02-08       Impact factor: 5.157

4.  SERINC5 Inhibits HIV-1 Infectivity by Altering the Conformation of gp120 on HIV-1 Particles.

Authors:  Austin Featherstone; Christopher Aiken
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

5.  Reduced Susceptibility to VIRIP-Based HIV-1 Entry Inhibitors Has a High Genetic Barrier and Severe Fitness Costs.

Authors:  Janis A Müller; Anna Glöckle; Ali Gawanbacht; Matthias Geyer; Jan Münch; Frank Kirchhoff
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

6.  Origins of resistance to the HIVgp41 viral entry inhibitor T20.

Authors:  Brian E McGillick; Trent E Balius; Sudipto Mukherjee; Robert C Rizzo
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

7.  The conserved residue Arg46 in the N-terminal heptad repeat domain of HIV-1 gp41 is critical for viral fusion and entry.

Authors:  Xiaoyi Wang; Weiliang Xiong; Xiaochu Ma; Meili Wei; Yanxia Chen; Lu Lu; Asim K Debnath; Shibo Jiang; Chungen Pan
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

8.  Efficient trapping of HIV-1 envelope protein by hetero-oligomerization with an N-helix chimera.

Authors:  Wu Ou; Jonathan Silver
Journal:  Retrovirology       Date:  2005-08-10       Impact factor: 4.602

9.  Structural and biochemical insights into the V/I505T mutation found in the EIAV gp45 vaccine strain.

Authors:  Jiansen Du; Xuefeng Wang; Jing Ma; Jianxin Wang; Yuyin Qin; Chunhui Zhu; Fang Liu; Yiming Shao; Jianhua Zhou; Wentao Qiao; Xinqi Liu
Journal:  Retrovirology       Date:  2014-03-21       Impact factor: 4.602

10.  The heptad repeat region is a major selection target in MERS-CoV and related coronaviruses.

Authors:  Diego Forni; Giulia Filippi; Rachele Cagliani; Luca De Gioia; Uberto Pozzoli; Nasser Al-Daghri; Mario Clerici; Manuela Sironi
Journal:  Sci Rep       Date:  2015-09-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.